Chemotherapy for Uterine Sarcomas

Chemo (chemotherapy) is the use of drugs to treat cancer. These drugs are usually given into a vein (IV) or taken by mouth and can reach and destroy cancer cells anywhere in the body. This makes chemo a useful treatment for cancer that has spread outside the uterus.

When is chemo used for uterine sarcoma?

Not everyone with uterine sarcoma will need chemo, but there are a few situations in which chemo might be recommended:

  • Instead of surgery, as the main treatment if surgery is not an option. It can be used alone or with radiation.
  • After surgery (adjuvant therapy), to lower the chance of cancer coming back.
  • To manage cancer spread, recurrence, and symptoms, for uterine sarcoma that has spread to other parts of the body or come back after surgery.

Chemo might not work for all types of uterine sarcoma. Some uterine sarcomas might respond better to certain drugs and drug combinations.

Which chemo drugs are used to treat uterine sarcoma?

The role of chemo, as well as which chemo drugs best treat uterine sarcomas, is not clear. Some of the drugs that might be used include:

  • Doxorubicin (Adriamycin)
  • Docetaxel
  • Gemcitabine
  • Ifosfamide
  • Dacarbazine (DTIC)
  • Cisplatin
  • Vinorelbine
  • Liposomal doxorubicin
  • Epirubicin
  • Temozolomide
  • Trabectedin

Sometimes, more than one drug is used. For example, gemcitabine and docetaxel might be used together to treat leiomyosarcoma.

Possible side effects of chemo

Chemo drugs affect cells that grow fast. Cancer cells multiply quickly, but so do other healthy cells in the body, including the blood-forming cells, hair cells, and cells that make up the lining of your gut. When chemo damages these fast-growing healthy cells, it can lead to side effects.

These side effects vary depending on the type of chemo drugs, the dose, and the length of time they are given.

Your cancer care team will watch you closely for side effects. Don’t hesitate to ask questions.

Short-term side effects

Some common short-term side effects of chemo drugs include:

  • Nausea and vomiting
  • Loss of appetite
  • Diarrhea or constipation
  • Hair loss
  • Mouth sores
  • Fatigue

Chemo can damage your bone marrow, where new blood cells are made. This can lower your blood cell counts, leading to:

  • Increased chance of infection from having too few white blood cells
  • Easy bleeding or bruising from low platelets
  • Fatigue or shortness of breath from low red blood cells

Controlling short-term side effects

Most short-term side effects go away after treatment is finished.

During treatment, there are ways to make these side effects less severe. For example, you can take medicines to help prevent and reduce nausea and vomiting or have a transfusion if your red blood cell or platelet count drops  too low. Tell your cancer care team about any side effects you have so they can help you control them.

Late effects

Late effects of chemo can take months or years to develop after treatment.

For example, some drugs can increase the risk of developing another type of cancer, such as leukemia, although this is rare. This small increase in risk should be weighed against the potential benefit of chemotherapy.

For more on the possible long-term effects of treatment, see After Treatment for Uterine Sarcoma.

Side effects of specific chemo drugs

Some chemo drugs have specific side effects.

Anthracycline chemo drugs can damage your heart muscle. This risk goes up with higher doses of the drug, so your cancer care team will watch your heart carefully during treatment and might limit your total dose or use medicines like dexrazoxane to lower the risk.

Ifosfamide can damage the lining of your bladder, which can cause blood in your urine. The risk of this happening can be lowered by taking the drugs with plenty of fluids.

These drugs might also damage the ovaries, which can affect their ability to make sex hormones like estrogen. In the case of uterine sarcoma, the ovaries might be surgically removed as a part of treatment.

Low sex hormones can affect sexual desire or pleasure, fertility, bone health, energy, and your brain’s ability to create new memories or complete tasks.

Cisplatin can cause neuropathy (nerve damage), leading to numbness, tingling, or pain in the hands and feet. This often goes away or gets better once treatment stops, but it might last a long time in some people.

These drugs can sometimes affect hearing, especially high-pitched sounds.

Kidney damage can also occur after treatment. Getting lots of fluids before and after you take these drugs can help prevent this.

Platinum chemo can also damage the ovaries, which can affect their ability to make sex hormones like estrogen. This can impact sex drive, sexual pleasure, bone health, fertility, energy, and your brain’s ability to create new memories or complete tasks.

More information about chemotherapy

For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.

To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.

side by side logos for 黑料大湿Posts Cancer Society and 黑料大湿Posts Society of Clinical Oncology

Developed by the 黑料大湿Posts Cancer Society medical and editorial content team with medical review and contribution by the 黑料大湿Posts Society of Clinical Oncology (ASCO).

Boggess JF, Kilgore JE, Tran AQ. Chapter 85: Uterine Cancer. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.

Hensley M, Leitao M. Treatment and prognosis of uterine leiomyosarcoma. UpToDate. 2026. Accessed at https://www.uptodate.com/contents/treatment-and-prognosis-of-uterine-leiomyosarcoma on February 17, 2026.

Lewis D, Liang A, Mason T, Ferriss JS. Current Treatment Options: Uterine Sarcoma. Curr Treat Options Oncol. 2024;25(7):829-853.

National Cancer Institute. Uterine Sarcoma Treatment. Accessed at https://www.cancer.gov/types/uterine/hp/uterine-sarcoma-treatment-pdq on February 17, 2026.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms Version 2.2026 – November 14, 2025. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf on February 17, 2026.

Ray-Coquard I, Casali PG, Croce S, et al. ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas. Int J Gynecol Cancer. 2024;34(10):1499-1521. Published 2024 Oct 7. 

Last Revised: June 9, 2026

黑料大湿Posts Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the 黑料大湿Posts Cancer Society.